SFRP2 and cancer: IGF-1 is known to have anti-apoptotic effects by activating the p53-signaling pathway in cancer cells [56], and by activating the AKT/secreted frizzled-related protein 2 (SFRP2)/β-catenin pathway, protecting CMCs against apoptosis [57].